Jiajia Zhang, Ph.D.

Core Co-Lead

Dr. Jiajia Zhang’s main research interests focus on investigating the association between the mortality/incidence of a certain disease with its potential risk factors using survival analysis. Specifically, her methodological research interests include investigating advanced survival models; such as the mixture cure model, spatial survival model, frailty model, and linear transformation model.

Dr. Wang’s current research is focused on mathematical and statistical modeling of data from electroencephalography (EEG), functional magnetic resonance imaging (fMRI) and diffusion tensor imaging (DTI) of clinical groups with brain disorders such as epilepsy. The main research topics that interest her are in joint modeling of structural and functional neuroimaging data, topological signal processing of neuroimaging time series, and topological brain network analysis.

Professor Wang’s research interests include computer vision, medical imaging, and machine learning. Recently, his research is focused on developing computational algorithms and software tools for understanding the natural images or image sequences by extracting perceptually salient structures, constructing statistical models for quantifying the nonrigid shape variation of anatomic structures, automatically and interactively segmenting structures of interest from various MR, CT, and microscopic images, detecting and recognizing objects of interest from images, and detecting and recognizing human activities in videos.

Dr. Hung’s primary research interests include rural health disparity, quality of care, spatial access to health services, and women health. Her research focuses on geographic disparities in hospital services and quality of health care in the national, state, and institutional levels (e.g. hospital, nursing home, etc.). Dr. Hung specializes in quantitative methods for health services research, using surveys and administrative data, along with econometrics to understand the effects of organizational structure, clinical, and policy intervention.

S. Scott Sutton, Pharm.D., is a Professor and Chair at the College of Pharmacy in the Department of Clinical Pharmacy and Outcomes Sciences. Additionally, he is a clinical researcher at the Dorn Research Institute / Veterans Affairs Medical Center and McGraw Hill Naplex author and pharmacy editor.

DeHart’s publications focus on violence and victimization, particularly pathways to crime and the incarceration of women and girls. She has recently co-authored book chapters and scientific journal articles on topics including, the role of substance abuse and mental health in female offending, the impact of incarceration on prisoners and their families, and developing a taxonomy of offenders who solicit children online. Her publications have been featured in scholarly journals, such as Psychology of Women Quarterly, Psychiatric Services, Criminal Justice & Behavior, and Prevention Science.

Currently, Chengwen is working on the identification of new adverse drug reactions, drug-drug interactions, and drug-disease interactions, and is comparing drug safety and effectiveness profiles using spontaneous reporting systems, electronic health records, and other databases. In addition to health outcomes research, Chengwen had research experience in pharmacology, immunology, and biochemistry.

Xueying Yang is a research assistant professor in the Department of Health Promotion, Education, and Behavior and with the South Carolina SmartState Center for Healthcare Quality. Her research interests focus on the health promotion of biomedical preventions for HIV infection (e.g. Antiretroviral Therapy (ART), Pre-exposure Prophylaxis (PreP)) through application of social and behavioral sciences.

Fan’s current research interests focus on cancer immunology; immunotherapy; the tumor microenvironment; natural compounds; inflammation; breast cancer; atherosclerosis.

Dr. Angela Murphy is committed to a health- related research career as evident by her 40 peer-reviewed journal articles in the area of complementary and alternative (CAM) treatment approaches to infection, inflammation and cancer. Her long-term career goal is to significantly contribute to expanding global knowledge in CAM treatments for cancer. This will largely involve sustaining an independent line of translational research, engaging in cutting edge techniques, publishing in high impact journals, presentations at meetings, training students and junior faculty, technology transfer and drug discovery.